Clinical Trials in Cancer and Pharmacogenomics: A Critical Evaluation

Journal of Clinical Trials
doi 10.4172/2167-0870.1000109
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OMICS Publishing Group

Related search

Pharmacogenomics in Early-Phase Oncology Clinical Trials: Is There a Sweet Spot in Phase II?

Clinical Cancer Research
Cancer ResearchOncology
2012English

Clinical Pharmacogenomics

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2018English

Cancer Pharmacogenomics

Pathology
Forensic MedicinePathology
2020English

Pharmacogenomics in Clinical Practice and Drug Development

Nature Biotechnology
Applied MicrobiologyBiotechnologyBiomedical EngineeringMolecular MedicineBioengineering
2012English

Critical Appraisal of Clinical Trials in Oncology — Part I

Oncology in Clinical Practice
Oncology
2019English

Pharmacogenomics Research and Clinical Implementation in Brazil

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2019English

Critical Appraisal of Clinical Trials in Oncology — Part II

Oncology in Clinical Practice
Oncology
2019English

The Evaluation of Clinical Trials.

Postgraduate Medical Journal
Medicine
1985English

Critical Review of Clinical Trials in Senile Dementia--I.

Postgraduate Medical Journal
Medicine
1987English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy